What are the key considerations for anticoagulant therapy in patients with end-stage renal disease, and how does impaired renal function affect treatment safety and efficacy?
Gaurav ChauhanContributor
What are the implications of anticoagulant therapy for patients with end-stage renal disease?
Share
1. In ESRD patients, monitor bleeding risk & adjust dosages as renal clearance of drugs is reduced, enhancing potential drug accumulation and toxicity.
2. Key considerations include choice of anticoagulant, as some have reduced clearance in ESRD, increasing hemorrhage risk; regular monitoring is essential.
3. Patients with ESRD require careful selection of anticoagulants and dose adjustments due to decreased renal elimination and increased bleeding risks.